Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies
Сенсорная стимуляция на гамма-частоте у пациентов с вероятной легкой деменцией при болезни Альцгеймера: результаты исследований осуществимости и пилотных исследований
2022-12-01
SCID: 54.1/cqnbvfs4
Discuss with AI
40Hz sensory stimulationGamma ENtrainment Using Sensory stimulation (GENUS)default mode networkhippocampal atrophymild Alzheimer’s disease dementia
Figures from the paper
Abstract (AI)
Non-invasive Gamma ENtrainment Using Sensory stimulation (GENUS) at 40Hz reduces Alzheimer's disease (AD) pathology such as amyloid and tau levels, prevents cerebral atrophy, and improves behavioral testing performance in mouse models of AD. Here, we report data from (1) a Phase 1 feasibility study (NCT04042922, ClinicalTrials.gov) in cognitively normal volunteers (n = 25), patients with mild AD dementia (n = 16), and patients with epilepsy who underwent intracranial electrode monitoring (n = 2) to assess safety and feasibility of a single brief GENUS session to induce entrainment and (2) a single-blinded, randomized, placebo-controlled Phase 2A pilot study (NCT04055376) in patients with mild probable AD dementia (n = 15) to assess safety, compliance, entrainment, and exploratory clinical outcomes after chronic daily 40Hz sensory stimulation for 3 months. Our Phase 1 study showed that 40Hz GENUS was safe and effectively induced entrainment in both cortical regions and other cortical and subcortical structures such as the hippocampus, amygdala, insula, and gyrus rectus. Our Phase 2A study demonstrated that chronic daily 40Hz light and sound GENUS was well-tolerated and that compliance was equally high in both the control and active groups, with participants equally inaccurate in guessing their group assignments prior to unblinding. Electroencephalography recordings show that our 40Hz GENUS device safely and effectively induced 40Hz entrainment in participants with mild AD dementia. After 3 months of daily stimulation, the group receiving 40Hz stimulation showed (i) lesser ventricular dilation and hippocampal atrophy, (ii) increased functional connectivity in the default mode network as well as with the medial visual network, (iii) better performance on the face-name association delayed recall test, and (iv) improved measures of daily activity rhythmicity compared to the control group. These results support further evaluation of GENUS in a pivotal clinical trial to evaluate its potential as a novel disease-modifying therapeutic for patients with AD.
Key Findings
1
A single brief 40Hz GENUS session was safe and induced neural entrainment in cortical regions and subcortical structures, including the hippocampus, amygdala, insula, and gyrus rectus.
2
Compared with controls, 40Hz stimulation was associated with lesser ventricular dilation and hippocampal atrophy after three months.
3
Electroencephalography confirmed that the GENUS device safely and effectively induced 40Hz entrainment in participants with mild probable Alzheimer’s dementia.
4
In a 3-month pilot study, daily 40Hz light-and-sound stimulation was well tolerated, with equally high compliance and ineffective group- assignment guessing in active and control groups.
5
The 40Hz group showed increased default mode network connectivity, better face-name delayed recall, and improved daily activity rhythmicity, supporting further pivotal evaluation.
Research Object
Patients with mild probable Alzheimer’s disease dementia receiving chronic daily 40Hz light and sound sensory stimulation
Research Subject
Safety, neural 40Hz entrainment, and exploratory clinical effects of GENUS, including brain atrophy, functional connectivity, memory performance, and daily activity rhythmicity
Publication Details
Publication Date
2022-12-01
Journal
Publisher
ISSN
Cited by
243
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment2005
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review2013
Older Adults' Reasons for Using Technology while Aging in Place2015
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease2011
Cited by7
An update on the use of gamma (multi)sensory stimulation for Alzheimer’s disease treatment2022
Brain Gamma-Stimulation: Mechanisms and Optimization of Impact2025
Artificial sharp-wave-ripples to support memory and counter neurodegeneration2023
Nonmedication Devices in Development for the Treatment of Alzheimer’s Disease2024
40 Hz audiovisual stimulation improves sustained attention and related brain oscillations2026
Auditory or Audiovisual Stimulation Ameliorates Cognitive Impairment and Neuropathology in ApoE4 Knock-In Mice2023
Gamma oscillations and application of 40‐Hz audiovisual stimulation to improve brain function2022